MiR-155 is another oncomir that controls many pathways associated with proliferation and reduced survival rates by targeting BRCA1, which was identified to play a part in DNA repair and initiation of BC and cell cycle progression (92). This evidence concerns the gene BRCA1 and breast cancer.